Mettler-Toledo International Inc (MTD)
1474.72
+19.61
(+1.35%)
USD |
NYSE |
Mar 20, 16:00
1475.99
+1.27
(+0.09%)
After-Hours: 20:00
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 32.60B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 4.95% |
| Valuation | |
| PE Ratio | 38.38 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 8.555 |
| Price to Book Value | 1316.04 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 81.25 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 36.32% |
News
Headline
Wire
Time (ET)
Yahoo
03/20 15:29
Yahoo
02/22 07:29
Events
| DATE | TIME | TYPE | PERIOD | REPORTED EPS |
ESTIMATED EPS |
SURPRISE | |
| 05/05/2023* | -- | Results | Q1 2023 | -- | 8.60 | -- | |
| 05/05/2023* | 17:00 EST | Earnings Call | Q1 2023 | -- | -- | -- | |
| 02/10/2023 | -- | Results | Q4 2022 | 12.10 | 11.68 | 3.57% | |
| 02/10/2023 | 08:30 EST | Earnings Call | Q4 2022 | -- | -- | -- | |
| 11/03/2022 | -- | Results | Q3 2022 | 10.18 | 9.83 | 3.53% | |
| 11/03/2022 | 17:00 EST | Earnings Call | Q3 2022 | -- | -- | -- | |
| 07/29/2022 | 07:00 EST | Earnings Call | Q2 2022 | -- | -- | -- | |
| 07/29/2022 | -- | Results | Q2 2022 | 9.39 | 8.77 | 7.04% |
*Estimated Date/Time
Earnings
Profile
Edit
| Mettler-Toledo International supplies weighing and precision instruments to customers in the life sciences, industrial, and food retail industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with sales distribution roughly as follows: United States around 30% of sales, Europe around 30%, China around 20%, and the rest of the world around 20%. |
| URL | https://www.mt.com |
| Investor Relations URL | https://www.mt.com/us/en/home/site_content/investors.html |
| HQ State/Province | Ohio |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Equity Style | Mid Cap/Growth |
| Next Earnings Release | May. 05, 2023 (est.) |
| Last Earnings Release | Feb. 10, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Dividends
| Dividend Per Share (TTM) | -- |
|
2017
2018
2019
2020
2021
6.00%
4.00%
2.00%
|
|
| Yield to Market | 0.00 |
| Yield to Sector | 0.00 |
| Yield to Industry | 0.00 |
| Last Dividend Amt. | -- |
| Dividend Frequency | -- |
| Last Ex-Dividend Date | -- |
| Yield (TTM) | 0.00% |
| Forward Yield | -- |
| Payout Ratio | 0.00% |
| Cash Payout Ratio | 0.00% |
| Consistent Payer (5Y) | No |
| Consistent Growth (5Y) | No |
Risk
Total Returns Comparison
Annual Total Returns Versus Peers
As of March 20, 2023.
Fundamentals
| Revenue (TTM) | 3.920B |
| Total Expenses (TTM) | 2.793B |
| Net Income (TTM) | 872.50M |
| Total Assets (Quarterly) | 3.492B |
| Total Liabilities (Quarterly) | 3.468B |
| Shareholders Equity (Quarterly) | 24.79M |
| Cash from Operations (TTM) | 859.07M |
| Cash from Investing (TTM) | -139.40M |
| Cash from Financing (TTM) | -716.04M |
Ratings
Profile
Edit
| Mettler-Toledo International supplies weighing and precision instruments to customers in the life sciences, industrial, and food retail industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with sales distribution roughly as follows: United States around 30% of sales, Europe around 30%, China around 20%, and the rest of the world around 20%. |
| URL | https://www.mt.com |
| Investor Relations URL | https://www.mt.com/us/en/home/site_content/investors.html |
| HQ State/Province | Ohio |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Equity Style | Mid Cap/Growth |
| Next Earnings Release | May. 05, 2023 (est.) |
| Last Earnings Release | Feb. 10, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ownership
| Insider Ownership Percentage | Upgrade |
Jul '20
Nov '20
Mar '21
80.00%
40.00%
10.00%
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Top Fund Holders
| Symbol | Dollars Invested | % Weight |
|---|---|---|
| BARUX | 261.80M USD | 6.04% |
| ETCGX | 161.89M USD | 4.95% |
| FBT | 47.95M USD | 3.36% |
| IBB | 254.32M USD | 3.20% |
| FGSRX | 318.01M USD | 2.08% |
| IGAF.TO | 74.56M USD | 1.86% |
| BMEZ | 33.03M USD | 1.58% |
| JMGQX | 125.36M USD | 1.52% |
| VMGIX | 218.15M USD | 1.09% |
| VOT | 218.15M USD | 1.09% |
| IWP | 109.95M USD | 0.94% |
| BBIEX | 120.34M USD | 0.78% |
Other Resources
| Whale Wisdom | 13F Filings |
| Seeking Alpha | Call Transcripts |
| Nasdaq | Insider Trading |
| Nasdaq | Institutional Ownership |
| Nasdaq | Option Chain |
| SEC | SEC Filings |
| MTD Tweets |